PK

Puneet Kansal

Active Director Director DIN 00365652
DIN 00365652 First appointment Oct 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Oct 2005
Shareholding value •••• Premium profile

About Puneet Kansal

Data last updated:

Puneet Kansal is a Director at Axa Parenterals Limited (since 2005), Whole-Time Director at Heilsa Life Sciences Private Limited (since 2021) and Director at Vaishno Fertilizer Private Limited (since 2016). The companies operate in Pharma, Agriculture and Machinery and Equipment. The 2 current companies with reported revenue have a combined latest revenue of ₹232 Cr; the largest is Axa Parenterals Limited at ₹231 Cr (FY 2025). Earlier, Puneet Kansal was a Director at Shreevasu Construction Equipments Private Limited (2015) and Whole-Time Director at Rsw Steel Private Limited (2018) and 1 more.

DIN 00365652
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2005
Oldest Company Age 21 yrs
Largest company Axa Parenterals Limited · ₹231 Cr (FY 2025)
Combined revenue ₹232 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axa Parenterals Limited U24232DL2005PLC148247
Director10 Oct 20052005₹231 Cr (FY 2025)Active
Heilsa Life Sciences Private Limited U24100DL2021PTC387167
Whole-Time Director26 Sep 20212021₹29.8 Lakh (FY 2025)Active
Vaishno Fertilizer Private Limited U24120UP2009PTC037482
Director06 Jan 20162009Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20152015Active
Rsw Steel Private Limited U28994DL2017PTC327608
Whole-Time Director16 Feb 20182017₹504 Cr (FY 2025)Active
Designated Partner30 Dec 20192019₹1.70 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vaishno Fertilizer Private Limited
Axa Parenterals Limited
Heilsa Life Sciences Private Limited
Shreevasu Construction Equipments Private Limited
Premium access

Shareholding and investment profile for Puneet Kansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Puneet Kansal

Puneet Kansal currently holds 3 directorships: Axa Parenterals Limited (Director, since 10 Oct 2005, revenue ₹231 Cr (FY 2025)); Heilsa Life Sciences Private Limited (Whole-Time Director, since 26 Sep 2021, revenue ₹29.8 Lakh (FY 2025)); Vaishno Fertilizer Private Limited (Director, since 06 Jan 2016).

Puneet Kansal was first appointed on 10 Oct 2005 as Director at Axa Parenterals Limited. The most recent appointment on record is 26 Sep 2021 at Heilsa Life Sciences Private Limited.

The 2 current companies of Puneet Kansal that report revenue have a combined latest revenue of ₹232 Cr: Axa Parenterals Limited ₹231 Cr (FY 2025); Heilsa Life Sciences Private Limited ₹29.8 Lakh (FY 2025).

Puneet Kansal held 3 earlier board appointments: Shreevasu Construction Equipments Private Limited (Director, 05 Jan 2015 to 25 May 2015); Rsw Steel Private Limited (Whole-Time Director, 16 Feb 2018 to 06 Sep 2018); Crop Care Organics Llp (Designated Partner, 30 Dec 2019 to 01 Feb 2021).

The current boards of Puneet Kansal's companies include Ruchir Gupta (Axa Parenterals Limited), Sumit Kumar Agarwal (Axa Parenterals Limited), Sunil Kumar Agarwal (Axa Parenterals Limited), Vijaysing Krupalsing Bhandari (Axa Parenterals Limited), Vikas Khanna (Axa Parenterals Limited), Yasha Agarwal (Axa Parenterals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available